Local Consolidative Therapy in Colorectal Cancer
Public ClinicalTrials.gov record NCT05062720. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
RT-167: Local Consolidative Therapy in Colorectal Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase II randomized multisite trial to study the effect of a combination of local consolidative therapy with systemic therapy in subjects with oligometastatic colorectal cancer who have progressed on the first line of therapy.
Study identification
- NCT ID
- NCT05062720
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 28, 2021
- Primary completion
- Dec 30, 2023
- Completion
- Oct 30, 2025
- Last update posted
- Dec 8, 2022
2021 – 2025
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Colorectal Cancer Metastatic trials
Other public records listing Colorectal Cancer Metastatic. Sorted by last update posted; newest first. Not a recommendation.
- NCT06698146: Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection Recruiting
- NCT07193862: Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis Recruiting
- NCT03657641: Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer Active, not recruiting
- NCT06300463: Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases Recruiting
- NCT07550088: BAL/BOT/agenT-797 in pMMR CRC With Liver Metastases Not yet recruiting
- NCT03038568: Assessing How Normal Variations in CT Scanning Affects Its Interpretation Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05062720, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 8, 2022 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05062720 live on ClinicalTrials.gov.